Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, China.
Research Center of Biomedical Engineering of Xiamen & Key Laboratory of Biomedical Engineering of Fujian Province, Department of Biomaterials, College of Materials, Xiamen University, Xiamen 361005, China.
Colloids Surf B Biointerfaces. 2018 Feb 1;162:76-89. doi: 10.1016/j.colsurfb.2017.10.061. Epub 2017 Oct 24.
The novel drug delivery system based on self-assembly of zinc phthalocyanine-soybean phosphatidylcholine (ZnPc-SPC) complex was developed by a co-solvent method followed by a nanoprecipitaion technique. DSPE-PEG-methotrexate (DSPE-PEG-MTX) was introduced on the surface of ZnPc-SPC self-assembled nanoparticles (ZS) to endow them with folate receptor-targeting property. NMR, XRD, FTIR, and UV-vis-NIR analysis demonstrated the weak molecular interaction between ZnPc and SPC. The ZS functionalized with DSPE-PEG-MTX (ZSPM) was successfully constructed with an average particle size of ∼170nm, a narrow size distribution, and could remain physiologically stable for at least 7days. In vitro cellular uptake and cytotoxicity studies demonstrated that ZSPM exhibited stronger cellular uptake efficacy and photodynamic cytotoxicity against HeLa and MCF-7 cells than ZS functionalized with DSPE-mPEG (ZSP) and free ZnPc. More importantly, ZSPM showed the enhanced accumulation effect at the tumor region compared with ZSP by the active-plus-passive targeting via enhanced permeability and retention (EPR) effect and folate receptor-mediated endocytosis. Furthermore, in vivo antitumor effect and histological analysis demonstrated the superior tumor growth inhibition effect of ZSPM. In addition, the needle-shape ZSP (ZSPN) exhibited better in vitro cellular uptake and in vivo tumor accumulation compared with ZSP due to the shape-assisted effect. Moreover, the interesting off-on switch effect of reactive oxygen species (ROS) production of ZnPc-SPC complex-based nanoparticles was discovered to achieve photodynamic treatment in a controllable way. These findings suggested that the ZnPc-SPC complex-based self-assembled nanoparticles could serve as a promising and effective formulation to achieve tumor-targeting fluorescence imaging and enhanced photodynamic treatment.
基于锌酞菁-大豆卵磷脂(ZnPc-SPC)复合物自组装的新型药物传递系统是通过共溶剂法和纳米沉淀技术开发的。在 ZnPc-SPC 自组装纳米粒子(ZS)的表面引入二硬脂酰基磷脂酰乙醇胺-聚乙二醇-甲氨蝶呤(DSPE-PEG-MTX),赋予其叶酸受体靶向性。NMR、XRD、FTIR 和 UV-vis-NIR 分析表明 ZnPc 和 SPC 之间存在较弱的分子相互作用。成功构建了 DSPE-PEG-MTX 功能化的 ZnPc-SPC 自组装纳米粒子(ZSPM),其平均粒径约为 170nm,粒径分布较窄,在生理条件下至少稳定 7 天。体外细胞摄取和细胞毒性研究表明,ZSPM 对 HeLa 和 MCF-7 细胞的细胞摄取效率和光动力细胞毒性均强于 DSPE-mPEG 功能化的 ZS(ZSP)和游离 ZnPc。更重要的是,通过增强型渗透和保留(EPR)效应和叶酸受体介导的内吞作用的主动加被动靶向,ZSPM 在肿瘤部位的积累效果明显优于 ZSP。此外,体内抗肿瘤效果和组织学分析表明,ZSPM 具有更好的肿瘤生长抑制作用。此外,由于形状辅助作用,针状 ZS(ZSPN)表现出比 ZSP 更好的体外细胞摄取和体内肿瘤积累。此外,还发现了基于 ZnPc-SPC 复合物的纳米粒子产生活性氧(ROS)的开-关开关效应,以实现可控的光动力治疗。这些发现表明,基于 ZnPc-SPC 复合物的自组装纳米粒子可以作为一种有前途和有效的制剂,实现肿瘤靶向荧光成像和增强光动力治疗。